Quinine (Quinine Dihydrochloride Fresenius)
Quinine
Fresenius Kabi Manufacturing SA (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Fresenius Kabi Manufacturing SA (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Quinine dihydrochloride 300 mg/1 ML fresenius EACH 1 ml SOLUTION CONTAINS QUININE DIHYDROCHLORIDE 300 mg | 300 mg/1 ml | 31026131/12/0261 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Quinine
- except preparations and mixures containing not more than 1 percent.
Consolidated Schedules 06 July 2026, line 7695
S2: Quinine
- preparations and mixtures containing not more than 1 percent thereof.
Consolidated Schedules 06 July 2026, line 2617
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.